期刊文献+

腹膜血管形成对腹膜透析失超滤的影响 被引量:5

The relationship between peritoneal neoangiogenesis and ultrafiltration failure in peritoneal dialysis patients
下载PDF
导出
摘要 目的 探讨腹膜透析失超滤的患病率及有关因素。方法 比较失超滤患者和非失超滤患者在透析龄、腹膜透析平衡试验 (PET)结果、腹膜炎、外周血白蛋白 (Alb)、高糖累积量及腹膜血管变化的差异。结果 失超滤患者的透析龄、腹膜通透性、高糖累积量及腹膜毛细血管的生成均高于非失超滤患者 ,但Alb相对较低 ;腹膜炎的患病率两组之间差异无显著性。结论 尿毒症环境、葡萄糖累积量的增多可能导致腹膜毛细血管的生成、腹膜的高转运 ,与腹膜透析的失超滤有关。 Objective To study the incidence and cause of ultrafiltration failure(UF) in peritoneal dialysis patients.Methods Respective analysis method was applied to investigate the relationship of the duration of peritoneal dialysis, peritonitis, serum albumin,high glucose accumulation(GA), peritoneal small molecular weight solute transport rate(PET),and peritoneal neoangiogenesis evaluated by detecting of the expression facter VIII by immunohistochemistry.Result The longer dialysis lasted,the higher rate of UF occured.GA and PET was higher,the increased expression of peritoneal neoangiogensis and serum albumin was lower in UF group compared with normal group.Peritonitis had no difference in two groups. Conclusion UF is mainly related with the duration of peritoneal dialysis and peritoneal neoangiogenesis.
出处 《中国血液净化》 2005年第3期133-135,共3页 Chinese Journal of Blood Purification
关键词 腹膜透析 失超滤 Peritoneal dialysis Ultrafiltration failure
  • 相关文献

参考文献6

  • 1Mujais S, Nolph K, Gokal, R et, al. Evalution and management of ultrafiltration problem in peritoneal dialysis, Internation Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int,2000, 20(suppl4) :S5- 21
  • 2Mciorca R,Cancarini GC,Zubani R, etal. CAPD viability:Along-term comparison with hemodialysis. Perit Dial Int, 1996, 16:276- 287
  • 3Kawaguchi Y. National comparisons: Optimal peritoneal dialysis outcome among Japanese patients. Perit Dial Int, 1999, 19 Supple 3:S9- 16
  • 4Heimburger O, Waniewski J, Werynski A, et al. Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity kidney. Kidney Int,1990, 38:495-506
  • 5De Vriese As, Mortier S, Lameire NH. What happens to the peritoneal membrane in long-term peritoneal dialysis? Perit Dial Int, 2001, 21(suppl3 ) :S9 - 18
  • 6Davies SJ,Phillips L, Naish PF, et al. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol,2001, 12:1046- 1051

同被引文献38

  • 1张晓东,钱家麒.尿毒症腹膜透析大鼠膈肌淋巴管新生的观察[J].微循环技术杂志(临床与实验),2004,8(5):288-290. 被引量:3
  • 2李惠军,王新文,李建初.彩色多普勒超声检测肠系膜上动脉血流的临床意义[J].诊断学理论与实践,2007,6(3):284-287. 被引量:5
  • 3Zakariael R, Spain DA, Harris PD, et al. Generalized dilation of the visceral mierovaseulature by peritoneal dialysis solutions. J Peritoneal Dialysis International, 2002,22(5):593-601.
  • 4Rieu P. End stage renal failure is a chronic inflammatory disease. Nephrologie, 2003,24(7) :329-333.
  • 5Inagi R, Miyata T, Yamamoto T, et al. Glucose degradation product methylglyoxal enhances the production of vascular endothelial growth factor in peritoneal membranes in peritoneal dialysis. J FEBS Letters, 1999,463(3) : 260-264.
  • 6Thomalley PJ. Advanced glycation end products in renal failure. J Ren Nutr, 2006,16(3) :178-184.
  • 7Margetts PJ,Gyorffy S,Kolb M,et al.Antiangiogenic and antifibrotic gene therapy in a chronic infusion model of peritoneal dialysis in rats.J Am Soc Nephrol,2002,13(3):721-728.
  • 8Williams JD,Craig KJ,Topley N,et al.Morphologic changes in the peritoneal membrane of patients with renal disease.J Am Soc Nephrol,2002,13(2):470-479.
  • 9Inagi R,Miyata T,Yamamoto T,et al.Glucose degradation pro-duct methylglyoxal enhances the production of vascular endothelial growth factor in peritoneal membranes in peritoneal dialysis.J FEBS Letters,1999,463,(3):260-264.
  • 10Davies SJ,Phillips L,Naish PF,et al.Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis.J Am Soc Nephrol,2001,12(5):1046-1051.

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部